Dr. Norma Sue Kenyon Joins NIH Council of Councils
The National Institutes of Health announced the appointment of nine new members to the NIH Council of Councils, including the Miller School’s Norma Sue Kenyon, Ph.D., the Martin Kleiman Professor of Surgery, Microbiology and Immunology, and Biomedical Engineering, Chief Innovation Officer of the Miller School and Program Director of Novel Methods at the Miami Clinical and Translational Science Institute (CTSI).
The Council of Councils advises the NIH Director on policies and activities of the Division of Program Coordination, Planning, and Strategic Initiatives. The council also makes recommendations for research that represents important areas of emerging scientific opportunities, rising public health challenges and scientific knowledge gaps that merit further research.
“I am honored to have this opportunity for engagement in strategic initiatives with the NIH,” said Kenyon, who is also UM’s Vice Provost for Innovation.
At the Miller School, Kenyon’s research in transplant immunology, specifically using biological replacement therapies for patients with type 1 diabetes, surpassed $2 million in NIH funding during the 2013 federal fiscal year. Additionally, Kenyon leads the Wallace H. Coulter Center for Translational Research, which promotes translational research in biomedical science and engineering by providing investigators with the core capabilities and expertise to move their projects from experimental findings to tangible applications that can impact public health.
A past fellow of the prestigious Hedwig van Ameringen Executive Leadership in Academic Medicine (ELAM) Program for Women at Drexel University College of Medicine in Philadelphia, Kenyon brings a broad and deep knowledge of the challenges facing academic health centers.
“I am delighted to welcome this distinguished group of leaders to the Council of Councils,” said James M. Anderson, M.D., Ph.D., Director of the Division of Program Coordination, Planning, and Strategic Initiatives at the NIH. “Collectively the council will inform our approach to foster new ideas based on analysis of the science. We will benefit greatly from their diverse perspectives, insight and experience.”
Kenyon will serve a three-year term on the council, which is composed of 27 members nominated by the NIH Institutes and Centers and from the Council of Public Representatives, an advisory committee to the NIH Office of the Director.